Colleen A. McHorney
Research Subjects
Colleen A. McHorney has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
E. Cha
Deciphera Pharmaceuticals, Inc., Waltham, MA, USA
1 shared publicationGary Globe
Affiliation Global Health Economics, Amgen, Thousand Oaks, CA, United States of America
1 shared publication- Hans-Christoph Becker
Department of Radiology, Stanford University, Stanford, California
1 shared publication Heather von Allmen
Merck & Co., Inc
1 shared publicationHeidi S. Wirtz
Affiliation Global Health Economics, Amgen, Thousand Oaks, CA, United States of America
1 shared publicationLeona E. Markson
Merck & Co., Inc
1 shared publication
Latest Publications
- Open Access
- 11 March 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3) , e0248240
The impact of heart failure on patients and caregivers: A qualitative study
Background: Heart failure is rising in prevalence but relatively little is known about the experiences and journey of patients and their caregivers. The goal of this paper is to present the symptom and symptom impact experiences of patients with heart failure and their caregivers.Methods: This was a United States-based study wherein in-person focus groups were conducted. Groups were audio recorded, transcribed and a content-analysis approach was used to analyze the data.Results: Ninety participants (64 patients and 26 caregivers) were included in the study. Most patients were female (52.0%) with mean age 59.3 ± 8 years; 55.6% were New York Heart Association Class II. The most commonly reported symptoms were shortness of breath (81.3%), fatigue/tiredness (76.6%), swelling of legs and ankles (57.8%), and trouble sleeping (50.0%). Patients reported reductions in social/family interactions (67.2%), dietary changes (64.1%), and difficulty walking and climbing stairs (56.3%) as the most common adverse disease impacts. Mental-health sequelae were noted as depression and sadness (43.8%), fear of dying (32.8%), and anxiety (32.8%). Caregivers (mean age 55.5 ± 11.2 years and 52.0% female) discussed 33 daily heart failure impacts, with the top three being reductions in social/family interactions (50.0%); being stressed, worried, and fearful (46.2%); and having to monitor their “patience” level (42.3%).Conclusions: There are serious unmet needs in HF for both patients and caregivers. More research is needed to better characterize these needs and the impacts of HF along with the development and evaluation of disease management toolkits that can support patients and their caregivers.
- 11 March 2021
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (3) , e0248240
Open AccessThe impact of heart failure on patients and caregivers: A qualitative study
Background: Heart failure is rising in prevalence but relatively little is known about the experiences and journey of patients and their caregivers. The goal of this paper is to present the symptom and symptom impact experiences of patients with heart failure and their caregivers.Methods: This was a United States-based study wherein in-person focus groups were conducted. Groups were audio recorded, transcribed and a content-analysis approach was used to analyze the data.Results: Ninety participants (64 patients and 26 caregivers) were included in the study. Most patients were female (52.0%) with mean age 59.3 ± 8 years; 55.6% were New York Heart Association Class II. The most commonly reported symptoms were shortness of breath (81.3%), fatigue/tiredness (76.6%), swelling of legs and ankles (57.8%), and trouble sleeping (50.0%). Patients reported reductions in social/family interactions (67.2%), dietary changes (64.1%), and difficulty walking and climbing stairs (56.3%) as the most common adverse disease impacts. Mental-health sequelae were noted as depression and sadness (43.8%), fear of dying (32.8%), and anxiety (32.8%). Caregivers (mean age 55.5 ± 11.2 years and 52.0% female) discussed 33 daily heart failure impacts, with the top three being reductions in social/family interactions (50.0%); being stressed, worried, and fearful (46.2%); and having to monitor their “patience” level (42.3%).Conclusions: There are serious unmet needs in HF for both patients and caregivers. More research is needed to better characterize these needs and the impacts of HF along with the development and evaluation of disease management toolkits that can support patients and their caregivers.
- 1 April 2007
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 10 (2) , S202
Persistency rates across weekly and monthly bisphosphonates: results from the IMS health longitudinal prescription database
- 1 April 2007
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 10 (2) , S202
Persistency rates across weekly and monthly bisphosphonates: results from the IMS health longitudinal prescription database